Osaka-Based Lobtex Enters Medical Device Business
This article was originally published in PharmAsia News
Osaka-based Japanese tool manufacturing company Lobtex will establish a new subsidiary, Lob Medical, in June as it enters the medical device business. With a fixed capital of ¥10 million and based inside Lobtex headquarters, Lob Medical will manufacture and market medical devices. Shuhei Yonegawa will become president of the new company, effective June 19. (Click here for more -- Japanese language
You may also be interested in...
With Roche's oral spinal muscular atrophy therapy Evrysdi off to a strong start after its recent US launch, Novartis is switching its priorities for rival RNA-splicing drug branaplam and putting it into a Phase IIb trial for Huntington's disease.
Nuvation started in 2018 and raised a $275m series A round in 2019. Now it is merging with the EcoR1 Capital-sponsored SPAC Panacea Acquisition Corp. and raising $500m in equity capital.
US FDA investigators' increased focus on aseptic operations is resulting in more Form 483 observations of microbiological contamination issues over the past few years.